Medicare Enrolled
Dr. Pierre Khoury, MD
Hematology & Oncology · Kingwood, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khoury from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khoury? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khoury
Dr. Pierre Khoury is a hematology & oncology in Kingwood, TX, with 20 years in practice. Based on federal Medicare data, Dr. Khoury performed 180,189 Medicare services across 1,834 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khoury received a total of $41,498 from 107 pharmaceutical and/or device companies across 1723 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khoury is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $41,498 industry payments
Medicare Practice Summary
Medicare Utilization ↗180,189
Medicare services
Top 2% in TX for hematology & oncology
1,834
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,009 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 119,250 | $1 | $3 |
| Anti-nausea injection (fosaprepitant) | 18,150 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 12,600 | $0 | $0 |
| Darbepoetin injection (Aranesp) for anemia | 8,500 | $2 | $8 |
| MRI contrast dye injection (gadoterate) | 6,850 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 3,780 | $18 | $54 |
| Dexamethasone injection (steroid) | 2,768 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,420 | $1 | $9 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,004 | $22 | $82 |
| Office visit, established patient (20-29 min) | 977 | $62 | $244 |
| Anti-nausea injection (ondansetron/Zofran) | 848 | $0 | $0 |
| Flow cytometry, additional marker | 541 | $19 | $62 |
| Administration of chemotherapy into vein, 1 hour or less | 463 | $100 | $375 |
| Office visit, established patient (30-39 min) | 378 | $94 | $347 |
| Drug injection, under skin or into muscle | 321 | $11 | $38 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 305 | $49 | $179 |
| Administration of chemotherapy into vein, each additional hour | 290 | $22 | $80 |
| Injection, diphenhydramine hcl, up to 50 mg | 274 | $1 | $3 |
| Injection, zoledronic acid, 1 mg | 232 | $7 | $24 |
| Administration of additional new drug or substance into vein, 1 hour or less | 188 | $49 | $183 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 169 | $16 | $112 |
| Irrigation of implanted venous access drug delivery device | 124 | $19 | $73 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 99 | $1,152 | $5,564 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 97 | $110 | $295 |
| Ct scan of abdomen and pelvis before and after contrast | 77 | $193 | $883 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 75 | $26 | $91 |
| Ct scan of chest before and after contrast | 74 | $76 | $517 |
| Injection of additional new drug or substance into vein | 69 | $12 | $44 |
| New patient office visit, complex (60-74 min) | 65 | $170 | $597 |
| New patient office visit (45-59 min) | 42 | $125 | $446 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $18 | $61 |
| Infusion into a vein for hydration, each additional hour | 24 | $10 | $36 |
| Infusion, normal saline solution , 1000 cc | 24 | $2 | $7 |
| Flow cytometry technique for dna or cell analysis, first marker | 22 | $50 | $189 |
| Office visit, established patient, complex (40-54 min) | 21 | $135 | $489 |
| Mri scan of brain before and after contrast | 17 | $167 | $863 |
| Drawing of blood for a medical problem | 14 | $64 | $276 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 11 | $128 | $476 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
67.0% high complexity
31.6% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$41,498
Total received (2018-2024)
Avg $5,928/year across 7 years
Top 14% in TX for hematology & oncology
107
Companies
1,723
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,834 (76.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,624 (20.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,040 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,995
2023$8,936
2022$5,494
2021$5,367
2020$3,299
2019$8,294
2018$4,112
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$3,017
Novartis Pharmaceuticals Corporation
$3,000
Genentech USA, Inc.
$2,925
Sirtex Medical Inc
$2,793
PFIZER INC.
$2,050
E.R. Squibb & Sons, L.L.C.
$2,009
GlaxoSmithKline, LLC.
$1,519
AstraZeneca Pharmaceuticals LP
$1,383
R-Pharm US LLC
$1,347
Amgen Inc.
$1,269
Seagen Inc.
$1,241
Merck Sharp & Dohme Corporation
$1,114
Daiichi Sankyo Inc.
$1,093
GENZYME CORPORATION
$906
Astellas Pharma US Inc
$809
Lilly USA, LLC
$783
Pharmacyclics LLC, An AbbVie Company
$762
Incyte Corporation
$711
Celgene Corporation
$701
Takeda Pharmaceuticals U.S.A., Inc.
$683
Eisai Inc.
$564
Dendreon Pharmaceuticals LLC
$514
Boehringer Ingelheim Pharmaceuticals, Inc.
$466
Merck Sharp & Dohme LLC
$466
ABBVIE INC.
$463
Gilead Sciences, Inc.
$451
Bayer HealthCare Pharmaceuticals Inc.
$393
Janssen Pharmaceuticals, Inc
$389
JAZZ PHARMACEUTICALS INC.
$384
Rigel Pharmaceuticals, Inc.
$327
Blueprint Medicines Corporation
$306
Foundation Medicine, Inc.
$300
Karyopharm Therapeutics Inc.
$281
AVEO Pharmaceuticals, Inc.
$253
MorphoSys, US Inc.
$252
RECORDATI_RARE_DISEASES_INC.
$250
EISAI INC.
$237
Regeneron Healthcare Solutions, Inc.
$232
Teva Pharmaceuticals USA, Inc.
$227
Mirati Therapeutics, Inc.
$216
Ipsen Biopharmaceuticals, Inc
$207
Bayer Healthcare Pharmaceuticals Inc.
$175
Clovis Oncology, Inc.
$166
Adaptive Biotechnologies Corporation
$162
TAIHO ONCOLOGY, INC.
$145
Kite Pharma, Inc.
$138
Exelixis Inc.
$133
Heron Therapeutics, Inc.
$120
TESARO, Inc.
$117
Pharmacyclics LLC, an AbbVie Company
$115
ADC Therapeutics America, Inc.
$110
SOBI, INC
$108
TerSera Therapeutics LLC
$102
SEAGEN INC.
$100
Puma Biotechnology, Inc.
$98
Alnylam Pharmaceuticals Inc.
$96
Dova Pharmaceuticals
$93
Taiho Oncology, Inc.
$90
Agios Pharmaceuticals, Inc.
$86
BeiGene USA, Inc.
$85
EMD Serono, Inc.
$80
Octapharma USA, Inc.
$80
Pharmacosmos Therapeutics Inc.
$76
ARRAY BIOPHARMA INC
$75
Blue Earth Diagnostics Limited
$75
Seattle Genetics, Inc.
$72
Alexion Pharmaceuticals, Inc.
$72
US Oncology Corporate, Inc.
$70
AbbVie Inc.
$70
Stemline Therapeutics Inc.
$69
Servier Pharmaceuticals LLC
$65
Sobi, Inc
$64
Sandoz Inc.
$63
Spectrum Pharmaceuticals Inc.
$62
G1 Therapeutics, Inc.
$62
Aveo Pharmaceuticals, Inc.
$60
SERVIER PHARMACEUTICALS LLC
$58
Aurobindo Pharma USA, Inc.
$57
CTI BioPharma Corp.
$50
SANOFI-AVENTIS U.S. LLC
$45
Biocompatibles, Inc.
$43
SpringWorks Therapeutics, Inc.
$40
Boston Scientific Corporation
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
Azurity Pharmaceuticals, Inc.
$36
Kyowa Kirin, Inc.
$35
MEDIVATION FIELD SOLUTIONS LLC
$31
Pharming Healthcare, Inc.
$30
Deciphera Pharmaceuticals Inc.
$27
Global Blood Therapeutics, Inc.
$26
Sumitomo Pharma America, Inc.
$22
Immunomedics, Inc.
$20
Myovant Sciences Inc.
$20
Immunocore Limited
$20
Genmab U.S., Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$19
Nestle HealthCare Nutrition Inc.
$19
PharmaEssentia USA Corporation
$18
Helsinn Therapeutics (U.S.), Inc.
$18
Apellis Pharmaceuticals, Inc.
$16
Tactile Systems Technology Inc
$16
Lexicon Pharmaceuticals, Inc.
$16
Tempus AI, Inc
$15
AbbVie, Inc.
$15
Secura Bio, Inc.
$14
Epizyme, Inc.,
$13
Medtronic USA, Inc.
$13
Top 3 companies account for 21.5% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · Axumin · BALVERSA · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · Creon · DALVANCE · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Flexitouch Plus · Folotyn · GAZYVA · GILOTRIF · Gazyva · HYQVIA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Monoferric · NERLYNX · NINLARO · NOURIANZ · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · OXLUMO · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETACRIT · RUCONEST · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · SYNAGIS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEFLARO · THERASPHERE - BIO · THERASPHERE-BIO · TIBSOVO · TRUSELTIQ · TUKYSA · Tavalisse · Tazverik · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · Truxima · ULTOMIRIS · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · WELIREG · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZARXIO · ZEJULA · ZENPEP · ZEPZELCA · ZIEXTENZO · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $23 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
41
Per 100K population
0.9
County median income
$73,104
Nearest hospital
KINGWOOD PINES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khoury is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khoury experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Khoury performed 119,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khoury receive payments from pharmaceutical companies?
Yes. Dr. Khoury received a total of $41,498 from 107 companies across 1,723 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khoury's costs compare to other hematology & oncologys in Kingwood?
Dr. Khoury's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khoury) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Kingwood
Browse hematology & oncologys in Kingwood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology